INFINITY PHARMACEUTICALS INC (INFI)

US45665G3039 - Common Stock

0.18  0 (0%)

TTM
(2023-3-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
2.67M2.59M1.86M1.70M3.00M
Cost Of Goods
1.61M1.56M1.12M1.00M7.30M
Gross Profit
1.06M1.03M738.00K700.00K-4.30M
Operating Expenses
45.01M45.87M45.82M39.20M41.40M
Operating Income
-43.94M-44.84M-45.08M-38.50M-45.70M
Interest Expense
966.00K475.00K-179.00K-2.00M-1.40M
Income Before Taxes
-42.98M-44.37M-45.26M-40.50M-47.10M
Income Tax
N/AN/AN/A0.00-100.00K
Net Income
-42.98M-44.37M-45.26M-40.50M-47.10M
EBITDA
-43.50M-44.39M-44.60M-38.00M-45.50M
 
Per Share Data
EPS Diluted Total Ops
-0.48-0.50-0.53-0.68-0.83
Non GAAP EPS
-0.48-0.50-0.53-0.67-0.82
 
Statistics
Gross Profit Margin
39.71%39.72%39.72%41.18%-143.33%
Profit Margin
-1608.46%-1711.11%-2436.06%-2382.35%-1570.00%
Operating Profit Margin
-1644.61%-1729.43%-2426.43%-2264.71%-1523.33%

All data in USD

Charts